Sfondo Header
L'angolo del dottorino
Search the site... Advanced search
✖

Aneurysms of peripheral arteries

Peripheral artery aneurysms are permanent, localized dilatations of arteries other than the aorta, characterized by an increase in diameter compared with that expected for the vessel concerned. The convention of a dilatation exceeding 50% of the normal calibre helps distinguish an aneurysm from simple ectasia, but requires an appropriate anatomical reference: diameter varies by location, sex and body build, and an adjacent segment that is already dilated does not necessarily represent normality. Diagnosis should describe the wall, outer dimensions, residual lumen, thrombus and relationships with surrounding tissues, rather than merely identify a wide vessel.

The risk is not limited to rupture. An aneurysm may cause thrombosis and embolization, compromise distal circulation or compress veins and nerves. In a popliteal artery aneurysm, the most characteristic threat is loss of limb perfusion, sometimes preceded by subtle microembolic events. A femoral artery aneurysm also raises issues related to the mass, the bifurcation and preservation of the profunda femoris artery. In visceral artery aneurysms, location and cause mainly determine the balance between haemorrhage risk and the need to preserve organ perfusion.

Among peripheral aneurysms of the limbs, popliteal aneurysms are the most frequent in vascular practice; true femoral aneurysms are less common and other sites are rare. Degenerative lesions are predominantly recognized in older men and may coexist with aortic aneurysms or aneurysms in other territories. This distribution does not encompass every cause: trauma, infection and arterial wall diseases may produce lesions in younger people. Surgical series, enriched for large or symptomatic cases, do not automatically describe the natural history of small, incidentally discovered dilatations.

Classification and significance of the aneurysm wall

In a true aneurysm, dilatation involves the arterial wall, even though its structure is profoundly altered. A pseudoaneurysm, by contrast, results from a breach in wall continuity: blood escapes from the lumen and is contained by surrounding tissues or an organized capsule, often remaining connected to the artery through a neck. This distinction affects natural history and treatment. A pulsatile collection after femoral puncture should not be equated with degenerative dilatation of the common femoral artery, and diameter thresholds studied for true aneurysms cannot automatically be applied to pseudoaneurysms.

The shape may be fusiform, involving the circumference along a segment, or saccular, with a more localized outpouching. Morphology provides clues but does not by itself establish the cause: a saccular lesion is not necessarily infected, and a fusiform lesion is not necessarily atherosclerotic. Dissection is a separate process in which blood separates layers of the arterial wall, although subsequent aneurysmal dilatation may accompany it. When present, these relationships should be clarified in the report, because the same maximum measurement can describe very different biological processes.

Clinical classification distinguishes asymptomatic aneurysms, symptomatic but uncomplicated aneurysms, and those complicated by ischemia, rupture or infection. The term asymptomatic must be used carefully: absence of pain does not exclude silent embolization or progressive loss of distal arteries. Similarly, a completely thrombosed aneurysm is not necessarily harmless. It may already have caused ischemia, continue to compress adjacent structures or require restoration of perfusion. Lesion anatomy and consequences for the supplied territory must be evaluated together.

Aetiology, pathogenesis and pathophysiology

Degenerative forms reflect a loss of integrity of the arterial wall matrix, with changes in elastic components, collagen remodelling and alterations in the cellular population. Inflammation and proteolytic degradation contribute to this process, but their roles are not identical in every artery, and much of the knowledge comes from aortic aneurysmal disease. Association with atherosclerosis is common and clinically relevant, but does not justify identifying an aneurysm as simply an enlarged plaque. Wall predisposition and mechanical stresses contribute to the dilatative phenotype.

The presence of multiple aneurysms suggests a systemic susceptibility that does not always correspond to an identifiable monogenic disorder. Unusually young age, marked family history, dissections, lesions in atypical locations or syndromic features warrant targeted assessment for inherited or inflammatory arterial disease. In other patients, a history of trauma, surgery or vascular access suggests a focal acquired lesion. Investigation of the cause should therefore start with the phenotype and clinical history, avoiding indiscriminate genetic testing while also avoiding an automatic label of degeneration for every dilatation.

Arterial infection may rapidly destroy the wall, cause a pseudoaneurysm or complicate a pre-existing lesion. Fever, bacteraemia, new local pain, tissue inflammation and rapid growth are important clues, but none must necessarily be present. Risk does not follow the same relationship with diameter as in stable degenerative aneurysms. Identifying the organism and controlling the infection focus become part of vascular treatment, and implanting material in a contaminated field requires a specific strategy.

Dilatation alters flow velocity and distribution, favouring recirculation zones and mural thrombus formation. Portions may detach and occlude smaller arteries; repeated events progressively diminish the distal vascular bed even while the main lumen remains open. This loss of outflow has two consequences: it increases ischemia risk and may reduce the durability of future reconstruction. Thrombus is therefore clinically relevant, not merely an imaging detail, but its presence alone does not establish a universal rule for intervention.

Rupture depends on wall strength and the stresses applied to it, with contributions from size, growth, shape and cause. In the limbs, expansion may also produce venous compression, oedema, venous thrombosis or neuropathy. In visceral territories, bleeding may be free, contained or enter adjacent structures, with different manifestations depending on the site. Applying one diameter threshold to all these situations would ignore substantial differences in risk.

Clinical manifestations and initial assessment

A pulsatile mass is an intuitive presentation but is not invariably present. Lesion depth, obesity or thrombosis may obscure pulsation; conversely, a nonvascular mass lying over an artery may transmit its pulse. Local pain, a sensation of pressure, oedema or paraesthesia may result from compression. Before puncturing, draining or biopsying a swelling near an arterial axis, a suitable test must exclude its vascular nature.

Ischemic manifestations include claudication, painful or cyanotic digits, skin lesions and, in acute complications, sudden pain, coldness, pallor and sensory or motor deficits. A proximal pulse does not exclude digital emboli. A new motor deficit indicates an especially urgent threat and calls for revascularization without avoidable delay. Palpation should extend throughout the limb and to the opposite limb, together with assessment of Doppler signals and tissue viability.

The history should establish when the swelling appeared and how it changed, previous embolic events, operations, arterial access procedures, trauma, infections and family history. Walking capacity, heart disease, renal function and antithrombotic medicines also need evaluation because they affect both presentation and treatment safety. Sudden pain with increasing swelling, bruising or instability suggests bleeding; in this setting, elective searches for other aneurysms are secondary to managing the emergency.

Investigations and diagnosis

Duplex Doppler ultrasound is often the first examination for accessible sites. It confirms continuity with the vessel, measures outer diameter and lumen, identifies thrombus and assesses flow, associated stenoses and distal arteries. In pseudoaneurysms it may reveal the neck and characteristic bidirectional flow across the communication. Assessing venous relationships is useful when oedema is present. Measurement quality depends on scan plane: an oblique section may overestimate diameter, while measuring only the lumen can underestimate a sac that is largely thrombosed.

CT angiography defines extent, branches, collateral vessels, access routes and possible signs of rupture or infection; it is particularly important for deep lesions or before complex reconstruction. MR angiography is an alternative when indicated, with limitations relating to acquisition time, devices and image quality. Catheter angiography primarily depicts the lumen and is used for selected questions or during procedures. It must not be used alone to exclude a completely thrombosed aneurysm, whose outer wall is not represented by arterial contrast filling alone.

Assessment of distal perfusion may include the ankle-brachial index, digital pressures and waveform analysis, selecting the method for the location and context. A normal index does not rule out an embolic source or an aneurysm that is still compensated. Blood counts, renal function and coagulation testing support planning and assessment of complications; inflammatory markers and blood cultures are appropriate when infection is suspected. No blood test can replace the anatomical characterization of the lesion.

Extent of disease and risk stratification

Diagnosing a peripheral aneurysm calls for consideration of associated lesions, particularly in the opposite vessel and the aortoiliac axis. This association is well documented for popliteal and femoral aneurysms, although frequencies depend on the populations studied. A reasoned pathway is used, often beginning with ultrasound and extending it according to findings and phenotype. This is different from offering whole-body CT to every patient or universal population screening for a relatively rare disease.

Risk estimation integrates diameter, growth and symptoms with thrombus, distal runoff, compression and cause. A small embolizing lesion may warrant earlier treatment than a larger but stable dilatation; an infected lesion or an evolving pseudoaneurysm follows different criteria again. Longitudinal comparisons should use consistent measurements and, wherever possible, the same technique. Small differences between operators or scan planes must not automatically be mistaken for biological acceleration of growth.

The decision also includes procedural risk and expected benefit. Frailty, life expectancy, availability of graft conduits, access anatomy and ability to comply with surveillance all change the balance. Indications cannot be inferred solely from the technical feasibility of placing a stent. At many rare sites, the literature predominantly consists of observational series and selected cases: this uncertainty must be acknowledged rather than presenting a threshold derived from non-equivalent populations as universal.

Principles of treatment

Surveillance is an active strategy for selected lesions: it involves clinical and imaging follow-up, comparison of growth, assessment of thrombus and clear instructions about symptoms requiring urgent care. Smoking cessation and management of blood pressure, lipids and comorbidities reduce cardiovascular risk where appropriate. However, no drug therapy has been shown to reliably reverse a degenerative peripheral aneurysm or remove its local risk. Antiplatelets and anticoagulants should be prescribed for specific indications, not as substitutes for necessary repair.

Open surgery may remove or exclude the aneurysmal segment and restore continuity using interposition or bypass grafting. When compression predominates, it also allows direct decompression of the sac. Reconstruction must preserve important branches and collaterals and use a conduit suitable for vessel calibre, site and possible contamination. Simply ligating an artery is not equivalent to repairing it: ligation is acceptable only when residual perfusion is adequate and the anatomy permits it.

Endovascular treatment uses covered stent grafts to separate the sac from blood flow, or selective embolization when occlusion of the vessel or particular branches can be tolerated. Adequate landing zones, feasible access and control of runoff are necessary. A joint, bifurcation or major organ-supplying branch may limit feasibility. Less initial invasiveness does not mean an absence of risk: thrombosis, loss of seal and persistent sac perfusion require surveillance and sometimes additional procedures.

In acute ischemia, treatment combines restoration of the distal vascular bed with management of the aneurysmal source. Urgency depends on limb viability; immediately threatened tissue cannot wait for prolonged thrombolysis. Rupture and infection instead prioritize haemostasis and control of the cause, together with preservation of perfusion. The approach may be surgical, endovascular or hybrid and must be designed around the dominant clinical problem.

Post-treatment surveillance and prognosis

Success includes patency of the reconstruction, sac exclusion, distal perfusion and symptom relief. These outcomes are not interchangeable: a patent bypass may coexist with a sac still supplied by collateral branches, while an excluded sac may coexist with stenosis of the reconstruction. Follow-up therefore assesses both, as well as growth of untreated aneurysms. Frequency and modality are adapted to location, technique and prior findings, with earlier reassessment if new symptoms arise.

Prognosis is generally better when treatment takes place before severe ischemia, rupture or infection. In individual patients, however, distal vascular bed condition, tissue quality, comorbidities and reconstruction durability are important. A patency percentage alone does not describe independence, pain or limb salvage. Even after successful repair, cardiovascular risk management and attention to possible aneurysmal disease in other territories remain important.

Complications

Disease complications include embolism, thrombosis and rupture, but also ischemic skin injury, tissue loss, venous compression and neurological damage. Recurrent embolization may leave distal circulation impaired before the aneurysm is recognized. In deep lesions, rupture may initially remain contained and present with pain and swelling without immediate collapse. Urgency assessment therefore requires more than blood pressure or the presence of pulsation alone.

After treatment, bleeding, infection, nerve injury, lymphatic complications, graft thrombosis and anastomotic stenosis may occur. An excluded sac may remain perfused and enlarge; a stent graft may develop mechanical or sealing problems. After reperfusion of a severely ischemic limb, muscle oedema and metabolic changes may require intensive care or fasciotomy. Prevention combines appropriate indications, planning, technique and follow-up over time, rather than considering the disease resolved when the operation ends.

References
  1. Johnston KW et al. Suggested standards for reporting on arterial aneurysms. Journal of Vascular Surgery. 1991;13(3):452-458.
  2. Farber A et al. The Society for Vascular Surgery clinical practice guidelines on popliteal artery aneurysms. Journal of Vascular Surgery. 2022;75(1S):109S-120S.
  3. Lawrence PF et al. The current management of isolated degenerative femoral artery aneurysms is too aggressive for their natural history. Journal of Vascular Surgery. 2014;59(2):343-349.
  4. Traina L et al. Incidence, Diagnosis, Treatment, and Outcomes of True Superficial Artery Aneurysms. Annals of Vascular Surgery. 2021;76:565-572.
  5. Diwan A et al. Incidence of femoral and popliteal artery aneurysms in patients with abdominal aortic aneurysms. Journal of Vascular Surgery. 2000;31(5):863-869.
  6. Zierler RE et al. The Society for Vascular Surgery practice guidelines on follow-up after vascular surgery arterial procedures. Journal of Vascular Surgery. 2018;68(1):256-284.
  7. Creager MA et al. Acute limb ischemia. The New England Journal of Medicine. 2012;366(23):2198-2206.
  8. Mazzolai L et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. European Heart Journal. 2024;45(36):3538-3700.
  9. Chaer RA et al. The Society for Vascular Surgery clinical practice guidelines on the management of visceral aneurysms. Journal of Vascular Surgery. 2020;72(1S):3S-39S.
  10. Koelemay MJ et al. European Society for Vascular Surgery (ESVS) 2025 Clinical Practice Guidelines on the Management of Diseases of the Mesenteric and Renal Arteries and Veins. European Journal of Vascular and Endovascular Surgery. 2025;70(2):153-218.

Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.

Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.